HTLV-1 p30(II): selective repressor of gene expression

por Green, Patrick L
Publicado 2004

The HBZ gene, a key player in HTLV-1 pathogenesis

por Matsuoka, Masao, Green, Patrick L
Publicado 2009

Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis

por Kannian, Priya, Green, Patrick L.
Publicado 2010

The need to accessorize: molecular roles of HTLV-1 p30 and HTLV-2 p28 accessory proteins in the viral life cycle

por Anupam, Rajaneesh, Doueiri, Rami, Green, Patrick L.
Publicado 2013

Cellular tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2)

por Kannian, Priya, Yin, Han, Doueiri, Rami, Green, Patrick L
Publicado 2011

Comparative virology of HTLV-1 and HTLV-2

por Martinez, Michael P., Al-Saleem, Jacob, Green, Patrick L.
Publicado 2019

CRISPR Genome Editing Applied to the Pathogenic Retrovirus HTLV-1

por Panfil, Amanda R., Green, Patrick L., Yoder, Kristine E.
Publicado 2020

Animal Models Utilized in HTLV-1 Research

por Panfil, Amanda R, Al-Saleem, Jacob J, Green, Patrick L
Publicado 2013

Functional comparison of the HTLV-1 and HTLV-2 antisense viral proteins: implications for pathogenesis

por Panfil, Amanda R, Dissinger, Nathan, Landes, Kristina, Green, Patrick L
Publicado 2015

Phosphorylation regulates human T-cell leukemia virus type 1 Rex function

por Kesic, Matthew, Doueiri, Rami, Ward, Michael, Semmes, O John, Green, Patrick L
Publicado 2009

HTLV-1 HBZ protein inhibits IRF3-mediated innate immune responses

por Douville, Renée N, Olière, Stéphanie, Green, Patrick L, Lin, Rongtuan, Hiscott, John
Publicado 2011

CRISPR/Cas9 Genome Editing to Disable the Latent HIV-1 Provirus

por Panfil, Amanda R., London, James A., Green, Patrick L., Yoder, Kristine E.
Publicado 2018

HTLV-1 bZIP factor enhances TGF-beta signaling through p300 coactivator

por Zhao, Tiejun, Satou, Yorifumi, Sugata, Kenji, Green, Patrick L, Imamura, Takeshi, Matsuoka, Masao
Publicado 2011

Role of protein arginine methyltransferase 5 over-expression in HTLV-1-driven cellular transformation and leukemia

por Panfil, Amanda R, Al-Saleem, Jacob J, Baiocchi, Robert A, Green, Patrick L
Publicado 2014

Human T-cell leukemia virus type 2 post-transcriptional control protein p28 is required for viral infectivity and persistence in vivo

por Yamamoto, Brenda, Li, Min, Kesic, Matthew, Younis, Ihab, Lairmore, Michael D, Green, Patrick L
Publicado 2008

Identification and Characterization of HTLV-1 HBZ Post-Translational Modifications

por Dissinger, Nathan, Shkriabai, Nikoloz, Hess, Sonja, Al-Saleem, Jacob, Kvaratskhelia, Mamuka, Green, Patrick L.
Publicado 2014

Comparative host protein interactions with HTLV-1 p30 and HTLV-2 p28: insights into difference in pathobiology of human retroviruses

por Doueiri, Rami, Anupam, Rajaneesh, Kvaratskhelia, Mamuka, Green, Kari B, Lairmore, Michael D, Green, Patrick L
Publicado 2012

Role of protein arginine methyltransferase 5 over-expression in HTLV-1-driven cellular transformation and leukemia

por Panfil, Amanda R, Al-Saleem, Jacob J, Kwiek, Jesse, Baiocchi, Robert A, Green, Patrick L
Publicado 2015

Stability of the HTLV-1 Antisense-Derived Protein, HBZ, Is Regulated by the E3 Ubiquitin-Protein Ligase, UBR5

por Panfil, Amanda R., Al-Saleem, Jacob, Howard, Cory M., Shkriabai, Nikoloz, Kvaratskhelia, Mamuka, Green, Patrick L.
Publicado 2018

The PRMT5 inhibitor EPZ015666 is effective against HTLV-1-transformed T-cell lines in vitro and in vivo

por Ernzen, Kyle, Melvin, Corrine, Yu, Lianbo, Phelps, Cameron, Niewiesk, Stefan, Green, Patrick L., Panfil, Amanda R.
Publicado 2023